ClinicalTrials.gg
CompletedNCT03528928Updated Dec 17, 2024Results posted

Viewing Surface Electrical Stimulation on Pelvic Floor With Ultrasound

An interventional study of Surface electrical stimulation in Pelvic Floor Disorders, sponsored by Elidah, Inc.. Completed at 1 site in United States. Open to female participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-17.

Sponsored by Elidah, Inc. · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 61 studies in Pelvic Floor Disorders with a site in United States — 12 open to participants now, 16 under way, none of them phase 3. Pelvic Floor Disorders · United States.

Enrollment
42nd of 50
8 · median 57
Started
2018
with 4 others
No phase
38 of 61
7 open now
Registered
26th of 61
by date

Among the 61 studies in Pelvic Floor Disorders with a site in United States, this one is the 42nd largest by enrollment of the 50 interventional ones that give a count, is one of 5 that started in 2018, is one of 38 with no phase, and was the 26th registered.

Pelvic Floor Disorders

212 studies on the registry are indexed under Pelvic Floor Disorders; 46 are open to participants now.

Browse Pelvic Floor Disorders studies →

Open to participants now

12 of the 61 studies in Pelvic Floor Disorders with a site in United States are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 27 Pelvic Floor Disorders studies recruiting now, 17 (63%) set no upper age limit and 10 (37%) stop at 75 or younger; none take children under 18; 9 take healthy volunteers.

This study: 18 Years to 80 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Pelvic Floor Disorders with a site in United States, or all of them as a file.
02

Study summary

Subjects will place a surface electrode on their perineal area after a bladder-filling protocol. Transabdominal ultrasound will image the base of the bladder at rest, voluntary pelvic floor contraction, with the surface electrical stimulation and with a combined pelvic floor contraction and electrical stimulation active.

03

Conditions studied

  • Pelvic Floor Disorders

Keywords

  • pelvic floor
  • electrical stimulation
  • bladder
  • ultrasound
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age:18-80y
  • Gender: female

Exclusion criteria

Exclusion Criteria:

  • Moderate-severe stress incontinence*: As determined by self-reported >3 accidents in 24-hr period
  • Currently pregnant, may be pregnant (Unsure pre and peri-menopausal women should take a pregnancy test.)
  • Active urinary tract infection (UTI)
  • Pelvic pain, Painful bladder syndrome, underlying neurologic/neuromuscular disorder that may impact ability to partake in the trial
  • implanted cardiac device or untreated cardiac arrhythmia
  • Obesity as defined by >= 30 (height, weight recorded)
  • Anyone with impaired decision making, drug or alcohol dependence, or potentially suicidal.
  • Anyone who lacks the capacity to consent for themselves or who requires a legal representative to give * Stress urinary incontinence: as determined by an answer of "Yes" to a standard question (from King's Health Questionnaire): "Do you lose urine with physical activities such as coughing, sneezing, running?"
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    Surface electrical stimulation

    Each subject did a Kegel pelvic floor contraction, had the surface electrical stimulation turned on at highest comfortable intensity, did a Kegel contraction with surface electrical stimulation on, and had second electrical stimulation turned on.

    Device: Surface electrical stimulation

Interventions

  • DeviceSurface electrical stimulation

    Thin electrode with four conductive areas placed over the perineal area.

    Also known as: Elitone

06

What researchers measure

Primary outcomes

  1. Movement of the Bladder

    Visualization of movement of the bladder with use of device by transabdominal ultrasound was captured and the measurement is measured in pixels for centroid magnitude displacement.

    Time frame: 1 Day

07

Results

Posted Dec 17, 2024

Participant flow

Participant flow — Overall Study
MilestoneSurface Electrical Stimulation
Started8
Completed8
Not completed0

Outcome measures

PrimaryMovement of the Bladder

Visualization of movement of the bladder with use of device by transabdominal ultrasound was captured and the measurement is measured in pixels for centroid magnitude displacement.

Time frame:
1 Day
Reported as:
Mean · pixels
Movement of the Bladder
pixelsSurface Electrical Stimulation
Movement of the Bladder23.1 ± 11.7

Adverse events

Collected over 1 day. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Surface Electrical Stimulation0/8 (0%)0/8 (0%)0/8 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Surface Electrical Stimulation
<=18 years0
Between 18 and 65 years8
>=65 years0
Age, Continuous
Age, Continuous(years)Surface Electrical Stimulation
Mean37.5 ± 8.8
Sex: Female, Male
Sex: Female, Male(Participants)Surface Electrical Stimulation
Female8
Male0
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Surface Electrical Stimulation
Region of Enrollment
Region of Enrollment(Participants)Surface Electrical Stimulation
United States8
BMI
BMI(lbs/ in^2)Surface Electrical Stimulation
Mean24.9 ± 4.3
08

Study locations

1 site
  • Wome's Health Advantage
    Fort Wayne, Indiana 46825, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2018 to primary completion in Apr 2018, 0 months.

Results were first posted in Dec 2024, 6 years 8 months after primary completion.

Of 106 interventional studies with no phase under Pelvic Floor Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's 0 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2018
First posted
May 18, 2018
StartActual
Apr 17, 2018
Primary completionActual
Apr 17, 2018
CompletionActual
Jan 21, 2019
Results first posted
Dec 17, 2024
Last update
Dec 17, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03528928
Lead sponsor
Elidah, Inc.
Responsible party
Sponsor
First posted
May 18, 2018
Start date
Apr 17, 2018
Primary completion
Apr 17, 2018
Completion
Jan 21, 2019
Results posted
Dec 17, 2024
Last update
Dec 17, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion